SABSW SAB BIOTHERAPEUTICS INC
FollowSPAC Combination (warrant or right), issuer CIK 1833214
6 managers (6 13F filers) reported a position in SABSW shares at 2026-03-31, 811,758 shares in all. 1 filer opened a position and 2 filers sold out during the quarter.
- Managers
- 6
- 13F filers
- 6
- New
- 1
- Added
- 0
- Reduced
- 3
- Sold out
- 2
- Shares held by filers
- 811,758
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q1 2026
Filers in the available 13F reports with a share position at 2026-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| LMR Partners LLPin group LMR Partners LLP | 539,588 | $14.1K | <0.01% | new | 13F-HRTimelineGroup |
| MORGAN STANLEYin group MORGAN STANLEY | 146,439 | $3.71K | <0.01% | 0 | 13F-HRTimelineGroup |
| Clear Street Group Inc.in group Clear Street Group Inc. | 78,733 | $2.06K | <0.01% | -100 | 13F-HRTimelineGroup |
| GTS SECURITIES LLC | 41,001 | $1.07K | <0.01% | -100 | 13F-HRTimeline |
| UBS Group AGin group UBS Group AG | 4,186 | $105 | <0.01% | -2,000 | 13F-HRTimelineGroup |
| WOLVERINE ASSET MANAGEMENT LLCin group WOLVERINE ASSET MANAGEMENT LLC | 1,811 | $47 | <0.01% | 0 | 13F-HRTimelineGroup |